The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel

{ 'indexed': {'date-parts': [[2023, 8, 12]], 'date-time': '2023-08-12T04:24:31Z', 'timestamp': 1691814271623}, 'reference-count': 151, 'publisher': 'Springer Science and Business Media LLC', 'issue': '6', 'license': [ { 'start': { 'date-parts': [[2023, 8, 11]], 'date-time': '2023-08-11T00:00:00Z', 'timestamp': 1691712000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}, { 'start': { 'date-parts': [[2023, 8, 11]], 'date-time': '2023-08-11T00:00:00Z', 'timestamp': 1691712000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1208/s12249-023-02627-3', 'type': 'journal-article', 'created': {'date-parts': [[2023, 8, 11]], 'date-time': '2023-08-11T14:02:25Z', 'timestamp': 1691762545000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe ' 'Hydroxychloroquine Inhalation Aerogel', 'prefix': '10.1208', 'volume': '24', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-0640-8085', 'authenticated-orcid': False, 'given': 'Mo’tasem M.', 'family': 'Alsmadi', 'sequence': 'first', 'affiliation': []}, {'given': 'Mays M.', 'family': 'Jaradat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rana M.', 'family': 'Obaidat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad', 'family': 'Alnaief', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rabab', 'family': 'Tayyem', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nasir', 'family': 'Idkaidek', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2023, 8, 11]]}, 'reference': [ { 'key': '2627_CR1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jddst.2021.102512', 'volume': '63', 'author': 'AEA da Silva', 'year': '2021', 'unstructured': 'da Silva AEA, de Abreu PMB, Geraldes DC, de Oliveira NL. ' 'Hydroxychloroquine: pharmacological, physicochemical aspects and ' 'activity enhancement through experimental formulations. J Drug Deliv Sci ' 'Technol. 2021;63:102512. https://doi.org/10.1016/j.jddst.2021.102512.', 'journal-title': 'J Drug Deliv Sci Technol.'}, { 'key': '2627_CR2', 'unstructured': 'Concardia. Plaquenil New Drug Application. 2007. ' 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009768. ' 'Accessed 23 Aug 2022.'}, { 'key': '2627_CR3', 'doi-asserted-by': 'publisher', 'first-page': '2227', 'DOI': '10.1093/cid/ciaa394', 'volume': '71', 'author': 'S Perinel', 'year': '2020', 'unstructured': 'Perinel S, Launay M, Botelho-Nevers É, Diconne É, Louf-Durier A, Lachand ' 'R, et al. Towards optimization of hydroxychloroquine dosing in intensive ' 'care unit COVID-19 patients. Clin Infect Dis. 2020;71:2227–9. ' 'https://doi.org/10.1093/cid/ciaa394.', 'journal-title': 'Clin Infect Dis.'}, { 'key': '2627_CR4', 'doi-asserted-by': 'publisher', 'first-page': '214', 'DOI': '10.1016/j.ijid.2020.01.050', 'volume': '92', 'author': 'S Zhao', 'year': '2020', 'unstructured': 'Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary ' 'estimation of the basic reproduction number of novel coronavirus ' '(2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the ' 'early phase of the outbreak. Int J Infect Dis. 2020;92:214–7. ' 'https://doi.org/10.1016/j.ijid.2020.01.050.', 'journal-title': 'Int J Infect Dis.'}, { 'key': '2627_CR5', 'unstructured': 'World Health Orgnization. WHO coronavirus (COVID-19) dashboard. 2023. ' 'https://covid19.who.int/. Accessed 16 June 2023.'}, { 'key': '2627_CR6', 'doi-asserted-by': 'publisher', 'first-page': '12', 'DOI': '10.1186/1745-6215-14-64', 'volume': '14', 'author': 'SR Kingsbury', 'year': '2013', 'unstructured': 'Kingsbury SR, Tharmanathan P, Adamson J, Arden NK, Birrell F, Cockayne ' "S, Dickson J, Doherty M, Dziedzic KS, Grainger A, Hewitt CE, O'Neill TW, " 'Scott DL, Vincent TL, Wakefield RJ, Watt FE, Torgerson DJ, Conaghan PG. ' 'Hydroxychloroquine effectiveness in reducing symptoms of hand ' 'osteoarthritis (HERO): study protocol for a randomized controlled trial. ' 'Trials Journal. 2013;14:12. https://doi.org/10.1186/1745-6215-14-64.', 'journal-title': 'Trials Journal.'}, { 'key': '2627_CR7', 'doi-asserted-by': 'publisher', 'first-page': '35', 'DOI': '10.1007/978-1-4939-0597-3', 'volume-title': 'Pharmacology of chloroquine and hydroxychloroquine. Hydroxychloroquine ' 'and chloroquine retinopathy', 'author': 'DJ Browning', 'year': '2014', 'unstructured': 'Browning DJ. Pharmacology of chloroquine and hydroxychloroquine. ' 'Hydroxychloroquine and chloroquine retinopathy. New York, NY: Springer; ' '2014. p. 35–63.'}, { 'key': '2627_CR8', 'doi-asserted-by': 'publisher', 'first-page': '303', 'DOI': '10.1111/j.1365-2125.1988.tb05281.x', 'volume': '26', 'author': 'S Tett', 'year': '1988', 'unstructured': 'Tett S, Cutler D, Day R, Brown K. A dose-ranging study of the ' 'pharmacokinetics of hydroxy-chloroquine following intravenous ' 'administration to healthy volunteers. Br J Clin Pharmacol. ' '1988;26:303–13. https://doi.org/10.1111/j.1365-2125.1988.tb05281.x.', 'journal-title': 'Br J Clin Pharmacol.'}, { 'key': '2627_CR9', 'first-page': '53', 'volume': '4', 'author': 'A Ferreira', 'year': '2014', 'unstructured': 'Ferreira A, Junior RTLM, Rosa TA, Rolim LA, Rolim-Neto PJ. Clinical, ' 'pharmacokinetic and technological aspects of the hydroxychloroquine ' 'sulfate. IOSR J Pharm. 2014;4:53–64.', 'journal-title': 'IOSR J Pharm.'}, { 'key': '2627_CR10', 'unstructured': 'Beau B, Furst DE. Hydroxychloroquine. In: Day RO, Fürst DE, Riel PLCM, ' 'Bresnihan B, editors. Antirheumatic therapy: actions and outcomes. 1st ' 'ed. Progress in Inflammation Research. Basel, switzerland: Birkhäuser ' 'Basel; 2005. p. 81-92.'}, { 'key': '2627_CR11', 'doi-asserted-by': 'publisher', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'volume': '71', 'author': 'X Yao', 'year': '2020', 'unstructured': 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral ' 'activity and projection of optimized dosing design of hydroxychloroquine ' 'for the treatment of severe acute respiratory syndrome coronavirus 2 ' '(SARS-CoV-2). Clin Infect Dis. 2020;71:732–9. ' 'https://doi.org/10.1093/cid/ciaa237.', 'journal-title': 'Clin Infect Dis.'}, { 'key': '2627_CR12', 'doi-asserted-by': 'publisher', 'first-page': '481', 'DOI': '10.1007/BF00315548', 'volume': '44', 'author': 'A McLachlan', 'year': '1993', 'unstructured': 'McLachlan A, Cutler D, Tett S. Plasma protein binding of the enantiomers ' 'of hydroxychloroquine and metabolites. Eur J Clin Pharmacol. ' '1993;44:481–4. https://doi.org/10.1007/BF00315548.', 'journal-title': 'Eur J Clin Pharmacol.'}, { 'key': '2627_CR13', 'doi-asserted-by': 'publisher', 'first-page': '447', 'DOI': '10.1124/jpet.117.245639', 'volume': '365', 'author': 'KP Collins', 'year': '2018', 'unstructured': 'Collins KP, Jackson KM, Gustafson DL. Hydroxychloroquine: a ' 'physiologically-based pharmacokinetic model in the context of ' 'cancer-related autophagy modulation. J Pharmacol Exp Ther. ' '2018;365:447–59. https://doi.org/10.1124/jpet.117.245639.', 'journal-title': 'J Pharmacol Exp Ther.'}, { 'key': '2627_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1127', 'DOI': '10.2174/1389200221999201208211537', 'volume': '21', 'author': 'S Rendic', 'year': '2020', 'unstructured': 'Rendic S, Guengerich FP. Metabolism and interactions of chloroquine and ' 'hydroxychloroquine with human cytochrome P450 enzymes and drug ' 'transporters. Curr Drug Metab. 2020;21:1127–35. ' 'https://doi.org/10.2174/1389200221999201208211537.', 'journal-title': 'Curr Drug Metab.'}, { 'key': '2627_CR15', 'doi-asserted-by': 'publisher', 'first-page': 'e00127', 'DOI': '10.1128/JVI.00127-20', 'volume': '94', 'author': 'Y Wan', 'year': '2020', 'unstructured': 'Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the ' 'novel coronavirus from Wuhan: an analysis based on decade-long ' 'structural studies of SARS coronavirus. J Virol. 2020;94:e00127–0. ' 'https://doi.org/10.1128/JVI.00127-20.', 'journal-title': 'J Virol.'}, { 'key': '2627_CR16', 'doi-asserted-by': 'publisher', 'first-page': '457', 'DOI': '10.1007/s11427-020-1637-5', 'volume': '63', 'author': 'X Xu', 'year': '2020', 'unstructured': 'Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the ' 'novel coronavirus from the ongoing Wuhan outbreak and modeling of its ' 'spike protein for risk of human transmission. Sci China Life Sci. ' '2020;63:457–60. https://doi.org/10.1007/s11427-020-1637-5.', 'journal-title': 'Sci China Life Sci.'}, { 'key': '2627_CR17', 'doi-asserted-by': 'publisher', 'first-page': '875', 'DOI': '10.1038/nm1267', 'volume': '11', 'author': 'K Kuba', 'year': '2005', 'unstructured': 'Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of ' 'angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung ' 'injury. Nat Med. 2005;11:875–9. https://doi.org/10.1038/nm1267.', 'journal-title': 'Nat Med.'}, { 'key': '2627_CR18', 'doi-asserted-by': 'publisher', 'first-page': '642', 'DOI': '10.1111/cts.12797', 'volume': '13', 'author': 'SLM Arnold', 'year': '2020', 'unstructured': 'Arnold SLM, Buckner F. Hydroxychloroquine for treatment of SARS-CoV-2 ' 'infection? Improving our confidence in a model-based approach to dose ' 'selection. Clin Transl Sci. 2020;13:642–5. ' 'https://doi.org/10.1111/cts.12797.', 'journal-title': 'Clin Transl Sci.'}, { 'key': '2627_CR19', 'doi-asserted-by': 'publisher', 'first-page': '24', 'DOI': '10.1128/AAC.00133-06', 'volume': '52', 'author': 'S Kiem', 'year': '2008', 'unstructured': 'Kiem S, Schentag JJ. Interpretation of antibiotic concentration ratios ' 'measured in epithelial lining fluid. Antimicrob Agents Chemother. ' '2008;52:24–36. https://doi.org/10.1128/AAC.00133-06.', 'journal-title': 'Antimicrob Agents Chemother.'}, { 'key': '2627_CR20', 'doi-asserted-by': 'publisher', 'first-page': '17', 'DOI': '10.1007/978-1-61779-319-6_2', 'volume': '790', 'author': 'L Franciosi', 'year': '2011', 'unstructured': 'Franciosi L, Govorukhina N, Ten Hacken N, Postma D, Bischoff R. ' 'Proteomics of epithelial lining fluid obtained by bronchoscopic ' 'microprobe sampling. Methods Mol Biol. 2011;790:17–28. ' 'https://doi.org/10.1007/978-1-61779-319-6_2.', 'journal-title': 'Methods Mol Biol.'}, { 'key': '2627_CR21', 'unstructured': 'Wilson KC, Chotirmall SH, Bai C, Rello J. COVID-19: interim guidance on ' 'management pending empirical evidence. From an American Thoracic ' 'Society-led International Task Force. 2020:12.'}, { 'key': '2627_CR22', 'doi-asserted-by': 'publisher', 'first-page': '6030', 'DOI': '10.1167/iovs.10-5278', 'volume': '51', 'author': 'YH Yoon', 'year': '2010', 'unstructured': 'Yoon YH, Cho KS, Hwang JJ, Lee S-J, Choi JA, Koh J-Y. Induction of ' 'lysosomal dilatation, arrested autophagy, and cell death by chloroquine ' 'in cultured ARPE-19 cells. Invest Ophthalmol Vis Sci. 2010;51:6030–7. ' 'https://doi.org/10.1167/iovs.10-5278.', 'journal-title': 'Invest Ophthalmol Vis Sci.'}, { 'key': '2627_CR23', 'doi-asserted-by': 'publisher', 'first-page': '4997', 'DOI': '10.1111/bph.15167', 'volume': '177', 'author': 'SC Fassihi', 'year': '2020', 'unstructured': 'Fassihi SC, Nabar NR, Fassihi R. Novel approach for low-dose pulmonary ' 'delivery of hydroxychloroquine in COVID-19. COVID-19. Research. ' '2020;177:4997–8. https://doi.org/10.1111/bph.15167.', 'journal-title': 'Research.'}, { 'key': '2627_CR24', 'doi-asserted-by': 'publisher', 'first-page': '405', 'DOI': '10.1016/j.healun.2020.03.012', 'volume': '39', 'author': 'HK Siddiqi', 'year': '2020', 'unstructured': 'Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed ' 'states: a clinical–therapeutic staging proposal. J Heart Lung ' 'Transplant. 2020;39:405–7. https://doi.org/10.1016/j.healun.2020.03.012.', 'journal-title': 'J Heart Lung Transplant.'}, { 'key': '2627_CR25', 'doi-asserted-by': 'publisher', 'first-page': '76', 'DOI': '10.1089/jamp.2022.0062', 'volume': '36', 'author': 'F Hawari', 'year': '2023', 'unstructured': 'Hawari F, Dodin Y, Tayyem R, Najjar S, Kakish H, Fara MA, et al. Safety, ' 'tolerability, and pharmacokinetics of nebulized hydroxychloroquine: a ' 'pilot study in healthy volunteers. J Aerosol Med Pulm Drug Deliv. ' '2023;36:76–81. https://doi.org/10.1089/jamp.2022.0062.', 'journal-title': 'J Aerosol Med Pulm Drug Deliv.'}, { 'key': '2627_CR26', 'doi-asserted-by': 'publisher', 'first-page': '2620', 'DOI': '10.1172/JCI137244', 'volume': '130', 'author': 'G Chen', 'year': '2020', 'unstructured': 'Chen G, Wu DI, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and ' 'immunological features of severe and moderate coronavirus disease 2019. ' 'J Clin Invest. 2020;130:2620–9. https://doi.org/10.1172/JCI137244.', 'journal-title': 'J Clin Invest.'}, { 'key': '2627_CR27', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijantimicag.2020.105982', 'volume': '55', 'author': 'M Zhao', 'year': '2020', 'unstructured': 'Zhao M. Cytokine storm and immunomodulatory therapy in COVID-19: role of ' 'chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob ' 'Agents. 2020;55:105982. ' 'https://doi.org/10.1016/j.ijantimicag.2020.105982.', 'journal-title': 'Int J Antimicrob Agents.'}, { 'key': '2627_CR28', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.mehy.2020.109783', 'volume': '142', 'author': 'A Klimke', 'year': '2020', 'unstructured': 'Klimke A, Hefner G, Will B, Voss U. Hydroxychloroquine as an aerosol ' 'might markedly reduce and even prevent severe clinical symptoms after ' 'SARS-CoV-2 infection. Med Hypotheses. 2020;142:109783. ' 'https://doi.org/10.1016/j.mehy.2020.109783.', 'journal-title': 'Med Hypotheses.'}, { 'key': '2627_CR29', 'doi-asserted-by': 'publisher', 'first-page': '250', 'DOI': '10.1055/a-1325-0248', 'volume': '71', 'author': 'FH Nasir Idkaidek', 'year': '2020', 'unstructured': 'Nasir Idkaidek FH, Dodin Y, Obeidat N. Development of a ' 'physiologically-based pharmacokinetic (PBPK) model of nebulized ' 'hydroxychloroquine for pulmonary delivery to COVID-19 patients. Drug ' 'Res. 2020;71:250–6. https://doi.org/10.1055/a-1325-0248.', 'journal-title': 'Drug Res.'}, { 'key': '2627_CR30', 'doi-asserted-by': 'publisher', 'first-page': 'e202422-e', 'DOI': '10.1001/jamapediatrics.2020.2422', 'volume': '174', 'author': 'AR Maharaj', 'year': '2020', 'unstructured': 'Maharaj AR, Wu H, Hornik CP, Balevic SJ, Hornik CD, Smith PB, et al. ' 'Simulated assessment of pharmacokinetically guided dosing for ' 'investigational treatments of pediatric patients with coronavirus ' 'disease 2019. JAMA Pediatr. 2020;174:e202422-e. ' 'https://doi.org/10.1001/jamapediatrics.2020.2422.', 'journal-title': 'JAMA Pediatr.'}, { 'key': '2627_CR31', 'doi-asserted-by': 'publisher', 'first-page': '919', 'DOI': '10.1007/s40264-018-0689-4', 'volume': '41', 'author': 'C Chatre', 'year': '2018', 'unstructured': 'Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers Y-M. Cardiac ' 'complications attributed to chloroquine and hydroxychloroquine: a ' 'systematic review of the literature. Drug Saf. 2018;41:919–31. ' 'https://doi.org/10.1007/s40264-018-0689-4.', 'journal-title': 'Drug Saf.'}, { 'key': '2627_CR32', 'doi-asserted-by': 'publisher', 'first-page': '1036', 'DOI': '10.1001/jamacardio.2020.1834', 'volume': '5', 'author': 'NJ Mercuro', 'year': '2020', 'unstructured': 'Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. ' 'Risk of QT interval prolongation associated with use of ' 'hydroxychloroquine with or without concomitant azithromycin among ' 'hospitalized patients testing positive for coronavirus disease 2019 ' '(COVID-19). JAMA Cardiol. 2020;5:1036–41. ' 'https://doi.org/10.1001/jamacardio.2020.1834.', 'journal-title': 'JAMA Cardiol.'}, { 'key': '2627_CR33', 'doi-asserted-by': 'publisher', 'DOI': '10.1161/JAHA.120.017144', 'volume': '9', 'author': 'A Ramireddy', 'year': '2020', 'unstructured': 'Ramireddy A, Chugh H, Reinier K, Ebinger J, Park E, Thompson M, et al. ' 'Experience with hydroxychloroquine and azithromycin in the coronavirus ' 'disease 2019 pandemic: implications for QT interval monitoring. J Am ' 'Heart Assoc. 2020;9:e017144. https://doi.org/10.1161/JAHA.120.017144.', 'journal-title': 'J Am Heart Assoc.'}, { 'key': '2627_CR34', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.mehy.2020.110110', 'volume': '143', 'author': 'O Kavanagh', 'year': '2020', 'unstructured': 'Kavanagh O, Healy AM, Dayton F, Robinson S, O’Reilly NJ, Mahoney B, et ' 'al. Inhaled hydroxychloroquine to improve efficacy and reduce harm in ' 'the treatment of COVID-19. Med Hypotheses. 2020;143:110110. ' 'https://doi.org/10.1016/j.mehy.2020.110110.', 'journal-title': 'Med Hypotheses.'}, { 'key': '2627_CR35', 'doi-asserted-by': 'publisher', 'first-page': '20', 'DOI': '10.1089/jamp.2020.1648', 'volume': '34', 'author': 'AH Albariqi', 'year': '2021', 'unstructured': 'Albariqi AH, Chang RYK, Tai W, Ke W-R, Chow MY, Tang P, et al. Inhalable ' 'hydroxychloroquine powders for potential treatment of COVID-19. J ' 'Aerosol Med Pulm Drug Deliv. 2021;34:20–31. ' 'https://doi.org/10.1089/jamp.2020.1648.', 'journal-title': 'J Aerosol Med Pulm Drug Deliv.'}, { 'key': '2627_CR36', 'doi-asserted-by': 'publisher', 'first-page': '2616', 'DOI': '10.3390/polym14132616', 'volume': '14', 'author': 'AS Ali', 'year': '2022', 'unstructured': 'Ali AS, Alrashedi MG, Ahmed OAA, Ibrahim IM. Pulmonary delivery of ' 'hydroxychloroquine nanostructured lipid carrier as a potential treatment ' 'of COVID-19. Polymers. 2022;14:2616. ' 'https://doi.org/10.3390/polym14132616.', 'journal-title': 'Polymers.'}, { 'key': '2627_CR37', 'doi-asserted-by': 'publisher', 'first-page': '333', 'DOI': '10.5731/pdajpst.2011.00717', 'volume': '65', 'author': 'PB Deshpande', 'year': '2011', 'unstructured': 'Deshpande PB, Kumar GA, Kumar AR, Shavi GV, Karthik A, Reddy MS, et al. ' 'Supercritical fluid technology: concepts and pharmaceutical ' 'applications. PDA J Pharm Sci Technol. 2011;65:333–44. ' 'https://doi.org/10.5731/pdajpst.2011.00717.', 'journal-title': 'PDA J Pharm Sci Technol.'}, { 'key': '2627_CR38', 'doi-asserted-by': 'publisher', 'first-page': '25', 'DOI': '10.1016/j.ijpharm.2009.04.047', 'volume': '377', 'author': 'E Badens', 'year': '2009', 'unstructured': 'Badens E, Majerik V, Horváth G, Szokonya L, Bosc N, Teillaud E, et al. ' 'Comparison of solid dispersions produced by supercritical antisolvent ' 'and spray-freezing technologies. Int J Pharm. 2009;377:25–34. ' 'https://doi.org/10.1016/j.ijpharm.2009.04.047.', 'journal-title': 'Int J Pharm.'}, { 'key': '2627_CR39', 'doi-asserted-by': 'publisher', 'first-page': '77', 'DOI': '10.1016/0378-3812(86)87007-8', 'volume': '32', 'author': 'WJ Schmitt', 'year': '1986', 'unstructured': 'Schmitt WJ, Reid RC. The use of entrainers in modifying the solubility ' 'of phenanthrene and benzoic acid in supercritical carbon dioxide and ' 'ethane. Fluid Phase Equilib. 1986;32:77–99. ' 'https://doi.org/10.1016/0378-3812(86)87007-8.', 'journal-title': 'Fluid Phase Equilib.'}, { 'key': '2627_CR40', 'doi-asserted-by': 'publisher', 'first-page': '9', 'DOI': '10.2147/IJN.S19021', 'volume': '6', 'author': 'M Kalani', 'year': '2011', 'unstructured': 'Kalani M, Yunus R. Application of supercritical antisolvent method in ' 'drug encapsulation: a review. Int J Nanomedicine. 2011;6:9–42. ' 'https://doi.org/10.2147/IJN.S19021.', 'journal-title': 'Int J Nanomedicine.'}, { 'key': '2627_CR41', 'doi-asserted-by': 'publisher', 'first-page': '373', 'DOI': '10.1016/j.addr.2006.12.001', 'volume': '60', 'author': 'OR Davies', 'year': '2008', 'unstructured': 'Davies OR, Lewis AL, Whitaker MJ, Tai H, Shakesheff KM, Howdle SM. ' 'Applications of supercritical CO 2 in the fabrication of polymer systems ' 'for drug delivery and tissue engineering. Adv Drug Deliv Rev. ' '2008;60:373–87. https://doi.org/10.1016/j.addr.2006.12.001.', 'journal-title': 'Adv Drug Deliv Rev.'}, { 'key': '2627_CR42', 'doi-asserted-by': 'publisher', 'first-page': '245', 'DOI': '10.1016/j.supflu.2007.10.002', 'volume': '44', 'author': 'ME Braga', 'year': '2008', 'unstructured': 'Braga ME, Pato MTV, Silva HSC, Ferreira EI, Gil MH, Duarte CM, et al. ' 'Supercritical solvent impregnation of ophthalmic drugs on chitosan ' 'derivatives. J Supercrit Fluids. 2008;44:245–57. ' 'https://doi.org/10.1016/j.supflu.2007.10.002.', 'journal-title': 'J Supercrit Fluids.'}, { 'key': '2627_CR43', 'doi-asserted-by': 'publisher', 'first-page': '91', 'DOI': '10.1016/j.supflu.2004.12.003', 'volume': '35', 'author': 'Q Tang', 'year': '2005', 'unstructured': 'Tang Q, Wang T. Preparation of silica aerogel from rice hull ash by ' 'supercritical carbon dioxide drying. J Supercrit Fluids. 2005;35:91–4. ' 'https://doi.org/10.1016/j.supflu.2004.12.003.', 'journal-title': 'J Supercrit Fluids.'}, { 'key': '2627_CR44', 'doi-asserted-by': 'publisher', 'first-page': '683', 'DOI': '10.1007/978-1-4419-7589-8_30', 'volume-title': 'Aerogels Handbook', 'author': 'W Yin', 'year': '2011', 'unstructured': 'Yin W, Rubenstein DA. Biomedical applications of aerogels. In: Aegerter ' 'M, Leventis N, Koebel M, editors. Aerogels Handbook. New York, NY: ' 'Springer; 2011. p. 683–94.'}, { 'key': '2627_CR45', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1155/2010/409310', 'volume': '2010', 'author': 'JL Gurav', 'year': '2010', 'unstructured': 'Gurav JL, Jung I-K, Park H-H, Kang ES, Nadargi DY. Silica aerogel: ' 'synthesis and applications. J Nanomater. 2010;2010:1–11. ' 'https://doi.org/10.1155/2010/409310.', 'journal-title': 'J Nanomater.'}, { 'key': '2627_CR46', 'doi-asserted-by': 'publisher', 'first-page': '1425', 'DOI': '10.1016/j.carbpol.2011.06.066', 'volume': '86', 'author': 'CA García-González', 'year': '2011', 'unstructured': 'García-González CA, Alnaief M, Smirnova I. Polysaccharide-based ' 'aerogels—promising biodegradable carriers for drug delivery systems. ' 'Carbohydr Polym. 2011;86:1425–38. ' 'https://doi.org/10.1016/j.carbpol.2011.06.066.', 'journal-title': 'Carbohydr Polym.'}, { 'key': '2627_CR47', 'doi-asserted-by': 'publisher', 'first-page': '738', 'DOI': '10.1007/s10971-016-3968-5', 'volume': '77', 'author': 'J Stergar', 'year': '2016', 'unstructured': 'Stergar J, Maver U. Review of aerogel-based materials in biomedical ' 'applications. J Solgel Sci Technol. 2016;77:738–52. ' 'https://doi.org/10.1007/s10971-016-3968-5.', 'journal-title': 'J Solgel Sci Technol.'}, { 'key': '2627_CR48', 'doi-asserted-by': 'publisher', 'first-page': '51', 'DOI': '10.1016/j.jconrel.2013.12.033', 'volume': '177', 'author': 'Z Ulker', 'year': '2014', 'unstructured': 'Ulker Z, Erkey C. An emerging platform for drug delivery: aerogel based ' 'systems. J Control Release. 2014;177:51–63. ' 'https://doi.org/10.1016/j.jconrel.2013.12.033.', 'journal-title': 'J Control Release.'}, { 'key': '2627_CR49', 'doi-asserted-by': 'publisher', 'first-page': '2472', 'DOI': '10.1016/j.jnoncrysol.2009.08.038', 'volume': '355', 'author': 'T Mehling', 'year': '2009', 'unstructured': 'Mehling T, Smirnova I, Guenther U, Neubert R. Polysaccharide-based ' 'aerogels as drug carriers. J Non Cryst Solids. 2009;355:2472–9. ' 'https://doi.org/10.1016/j.jnoncrysol.2009.08.038.', 'journal-title': 'J Non Cryst Solids.'}, { 'key': '2627_CR50', 'doi-asserted-by': 'publisher', 'first-page': '1823', 'DOI': '10.1124/dmd.115.065920', 'volume': '43', 'author': 'JE Sager', 'year': '2015', 'unstructured': 'Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N. Physiologically ' 'based pharmacokinetic (PBPK) modeling and simulation approaches: a ' 'systematic review of published models, applications, and model ' 'verification. Drug Metab Dispos. 2015;43:1823–37. ' 'https://doi.org/10.1124/dmd.115.065920.', 'journal-title': 'Drug Metab Dispos.'}, { 'key': '2627_CR51', 'doi-asserted-by': 'publisher', 'first-page': '430', 'DOI': '10.1016/j.apsb.2016.04.004', 'volume': '6', 'author': 'X Zhuang', 'year': '2016', 'unstructured': 'Zhuang X, Lu C. PBPK modeling and simulation in drug research and ' 'development. Acta Pharm Sin B. 2016;6:430–40. ' 'https://doi.org/10.1016/j.apsb.2016.04.004.', 'journal-title': 'Acta Pharm Sin B.'}, { 'key': '2627_CR52', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/psp.2013.41', 'volume': '2', 'author': 'HM Jones', 'year': '2013', 'unstructured': 'Jones HM, Rowland-Yeo K. Basic concepts in physiologically based ' 'pharmacokinetic modeling in drug discovery and development. CPT ' 'Pharmacometrics Syst Pharmacol. 2013;2:1–12. ' 'https://doi.org/10.1038/psp.2013.41.', 'journal-title': 'CPT Pharmacometrics Syst Pharmacol.'}, { 'key': '2627_CR53', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/psp.2013.29', 'volume': '2', 'author': 'M Rowland', 'year': '2013', 'unstructured': 'Rowland M. Physiologically-based pharmacokinetic (PBPK) modeling and ' 'simulations principles, methods, and applications in the pharmaceutical ' 'industry. CPT Pharmacometrics Syst Pharmacol. 2013;2:e55. ' 'https://doi.org/10.1038/psp.2013.29.', 'journal-title': 'CPT Pharmacometrics Syst Pharmacol.'}, { 'key': '2627_CR54', 'doi-asserted-by': 'publisher', 'first-page': '161', 'DOI': '10.1007/s40495-016-0059-9', 'volume': '2', 'author': 'M Jamei', 'year': '2016', 'unstructured': 'Jamei M. Recent advances in development and application of ' 'physiologically-based pharmacokinetic (PBPK) models: a transition from ' 'academic curiosity to regulatory acceptance. Curr Pharmacol Rep. ' '2016;2:161–9. https://doi.org/10.1007/s40495-016-0059-9.', 'journal-title': 'Curr Pharmacol Rep.'}, { 'key': '2627_CR55', 'doi-asserted-by': 'publisher', 'first-page': '481', 'DOI': '10.1007/s10928-016-9492-y', 'volume': '43', 'author': 'C Hartmanshenn', 'year': '2016', 'unstructured': 'Hartmanshenn C, Scherholz M, Androulakis IP. Physiologically-based ' 'pharmacokinetic models: approaches for enabling personalized medicine. J ' 'Pharmacokinet Pharmacodyn. 2016;43:481–504. ' 'https://doi.org/10.1007/s10928-016-9492-y.', 'journal-title': 'J Pharmacokinet Pharmacodyn.'}, { 'key': '2627_CR56', 'doi-asserted-by': 'publisher', 'first-page': '605', 'DOI': '10.1002/psp4.12034', 'volume': '4', 'author': 'L Gaohua', 'year': '2015', 'unstructured': 'Gaohua L, Wedagedera J, Small BG, Almond L, Romero K, Hermann D, et al. ' 'Development of a multicompartment permeability-limited lung PBPK model ' 'and its application in predicting pulmonary pharmacokinetics of ' 'antituberculosis drugs. CPT Pharmacometrics Syst Pharmacol. ' '2015;4:605–13. https://doi.org/10.1002/psp4.12034.', 'journal-title': 'CPT Pharmacometrics Syst Pharmacol.'}, { 'key': '2627_CR57', 'doi-asserted-by': 'publisher', 'first-page': '185', 'DOI': '10.1111/jphp.13201', 'volume': '72', 'author': 'Y Kong', 'year': '2020', 'unstructured': 'Kong Y, Cai H, Xing H, Ren C, Kong D, Ning C, et al. Pulmonary delivery ' 'alters the disposition of raloxifene in rats. J Pharm Pharmacol. ' '2020;72:185–96. https://doi.org/10.1111/jphp.13201.', 'journal-title': 'J Pharm Pharmacol.'}, { 'key': '2627_CR58', 'doi-asserted-by': 'publisher', 'first-page': '725', 'DOI': '10.1080/10408444.2019.1692780', 'volume': '49', 'author': 'AR Kolli', 'year': '2019', 'unstructured': 'Kolli AR, Kuczaj AK, Martin F, Hayes AW, Peitsch MC, Hoeng J. Bridging ' 'inhaled aerosol dosimetry to physiologically based pharmacokinetic ' 'modeling for toxicological assessment: nicotine delivery systems and ' 'beyond. Crit Rev Toxicol. 2019;49:725–41. ' 'https://doi.org/10.1080/10408444.2019.1692780.', 'journal-title': 'Crit Rev Toxicol.'}, { 'key': '2627_CR59', 'unstructured': 'Hydroxychloroquinle Sulfate. The Pharmacopeia of the United States of ' 'America. Rockville, MD. 2019. Accessed 14 Sept 2022.'}, { 'key': '2627_CR60', 'doi-asserted-by': 'publisher', 'first-page': '47', 'DOI': '10.2174/1574884710666150817104746', 'volume': '11', 'author': 'R Mehvar', 'year': '2016', 'unstructured': 'Mehvar R. Application of organ clearance to estimation of the in vivo ' 'hepatic extraction ratio. Curr Clin Pharmacol. 2016;11:47–52. ' 'https://doi.org/10.2174/1574884710666150817104746.', 'journal-title': 'Curr Clin Pharmacol.'}, { 'key': '2627_CR61', 'doi-asserted-by': 'publisher', 'first-page': '157', 'DOI': '10.4155/fmc-2020-0187', 'volume': '13', 'author': 'RP Dash', 'year': '2020', 'unstructured': 'Dash RP, Veeravalli V, Thomas JA, Rosenfeld C, Mehta N, Srinivas NR. ' 'Whole blood or plasma: what is the ideal matrix for ' 'pharmacokinetic-driven drug candidate selection? Future Med Chem. ' '2020;13:157–71. https://doi.org/10.4155/fmc-2020-0187.', 'journal-title': 'Future Med Chem.'}, { 'key': '2627_CR62', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0247356', 'volume': '16', 'author': 'V Sok', 'year': '2021', 'unstructured': 'Sok V, Marzan F, Gingrich D, Aweeka F, Huang L. Development and ' 'validation of an LC-MS/MS method for determination of ' 'hydroxychloroquine, its two metabolites, and azithromycin in ' 'EDTA-treated human plasma. PLoS One. 2021;16:e0247356. ' 'https://doi.org/10.1371/journal.pone.0247356.', 'journal-title': 'PLoS One.'}, { 'key': '2627_CR63', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.18637/jss.v033.i03', 'volume': '33', 'author': 'K Soetaert', 'year': '2010', 'unstructured': 'Soetaert K, Petzoldt T. Inverse modelling, sensitivity and monte carlo ' 'analysis in R using package FME. J Stat Softw. 2010;33:1–28. ' 'https://doi.org/10.18637/jss.v033.i03.', 'journal-title': 'J Stat Softw.'}, { 'key': '2627_CR64', 'doi-asserted-by': 'publisher', 'first-page': '575', 'DOI': '10.1007/s10953-010-9517-x', 'volume': '39', 'author': 'R Obaidat', 'year': '2010', 'unstructured': 'Obaidat R, Al-Jbour N, Al-Sou’d K, Sweidan K, Al-Remawi M, Badwan A. ' 'Some physico-chemical properties of low molecular weight chitosans and ' 'their relationship to conformation in aqueous solution. J Solution Chem. ' '2010;39:575–88. https://doi.org/10.1007/s10953-010-9517-x.', 'journal-title': 'J Solution Chem.'}, { 'key': '2627_CR65', 'doi-asserted-by': 'publisher', 'first-page': '2223', 'DOI': '10.3390/polym12102223', 'volume': '12', 'author': 'M Alnaief', 'year': '2020', 'unstructured': 'Alnaief M, Obaidat RM, Alsmadi MM. Preparation of hybrid ' 'alginate-chitosan aerogel as potential carriers for pulmonary drug ' 'delivery. Polymers. 2020;12:2223. https://doi.org/10.3390/polym12102223.', 'journal-title': 'Polymers.'}, { 'key': '2627_CR66', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1208/s12249-020-01735-8', 'volume': '21', 'author': 'MM Alsmadi', 'year': '2020', 'unstructured': 'Alsmadi MM, Obaidat RM, Alnaief M, Albiss BA, Hailat N. Development, In ' 'vitro characterization, and in vivo toxicity evaluation of ' 'chitosan-alginate nanoporous carriers loaded with cisplatin for lung ' 'cancer treatment. AAPS PharmSciTech. 2020;21:1–12. ' 'https://doi.org/10.1208/s12249-020-01735-8.', 'journal-title': 'AAPS PharmSciTech.'}, { 'key': '2627_CR67', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.supflu.2020.104882', 'volume': '163', 'author': 'P dos Santos', 'year': '2020', 'unstructured': 'dos Santos P, Viganó J, de Figueiredo FG, Cunha RL, Hubinger MD, Rezende ' 'CA, et al. Production of resveratrol loaded alginate aerogel: ' 'characterization, mathematical modeling, and study of impregnation. J ' 'Supercrit Fluids. 2020;163:104882. ' 'https://doi.org/10.1016/j.supflu.2020.104882.', 'journal-title': 'J Supercrit Fluids.'}, { 'key': '2627_CR68', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.molliq.2020.114539', 'volume': '322', 'author': 'M Pishnamazi', 'year': '2021', 'unstructured': 'Pishnamazi M, Hosseini S, Zabihi S, Borousan F, Hezave AZ, Marjani A, et ' 'al. Chloroquine (antimalaria medication with anti SARS-CoV activity) ' 'solubility in supercritical carbon dioxide. J Mol Liq. 2021;322:114539. ' 'https://doi.org/10.1016/j.molliq.2020.114539.', 'journal-title': 'J Mol Liq.'}, { 'key': '2627_CR69', 'doi-asserted-by': 'publisher', 'first-page': '1235', 'DOI': '10.1208/s12249-015-0312-2', 'volume': '16', 'author': 'RM Obaidat', 'year': '2015', 'unstructured': 'Obaidat RM, Tashtoush BM, Bayan MF, Al Bustami RT, Alnaief M. Drying ' 'using supercritical fluid technology as a potential method for ' 'preparation of chitosan aerogel microparticles. AAPS PharmSciTech. ' '2015;16:1235–44. https://doi.org/10.1208/s12249-015-0312-2.', 'journal-title': 'AAPS PharmSciTech.'}, { 'key': '2627_CR70', 'doi-asserted-by': 'publisher', 'first-page': '264', 'DOI': '10.1016/j.carbpol.2017.10.038', 'volume': '180', 'author': 'M Alnaief', 'year': '2018', 'unstructured': 'Alnaief M, Obaidat R, Mashaqbeh H. Effect of processing parameters on ' 'preparation of carrageenan aerogel microparticles. Carbohydr Polym. ' '2018;180:264–75. https://doi.org/10.1016/j.carbpol.2017.10.038.', 'journal-title': 'Carbohydr Polym.'}, { 'key': '2627_CR71', 'doi-asserted-by': 'publisher', 'first-page': '106', 'DOI': '10.1208/s12249-021-01962-7', 'volume': '22', 'author': 'R Obaidat', 'year': '2021', 'unstructured': 'Obaidat R, Aleih H, Mashaqbeh H, Altaani B, Alsmadi MTM, Alnaief M. ' 'Development and evaluation of cocoa butter taste masked ibuprofen using ' 'supercritical carbon dioxide. AAPS PharmSciTech. 2021;22:106. ' 'https://doi.org/10.1208/s12249-021-01962-7.', 'journal-title': 'AAPS PharmSciTech.'}, { 'key': '2627_CR72', 'doi-asserted-by': 'publisher', 'first-page': '199', 'DOI': '10.1016/j.ejps.2017.12.012', 'volume': '114', 'author': 'JM Unagolla', 'year': '2018', 'unstructured': 'Unagolla JM, Jayasuriya AC. Drug transport mechanisms and in vitro ' 'release kinetics of vancomycin encapsulated chitosan-alginate ' 'polyelectrolyte microparticles as a controlled drug delivery system. Eur ' 'J Pharm Sci. 2018;114:199–209. ' 'https://doi.org/10.1016/j.ejps.2017.12.012.', 'journal-title': 'Eur J Pharm Sci.'}, { 'key': '2627_CR73', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.colsurfb.2021.112249', 'volume': '210', 'author': 'Y He', 'year': '2022', 'unstructured': 'He Y, Xu Y, Huang Y, Quang H, Xia X, Zhao H, et al. Redox sensitive ' 'nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine ' 'conjugates for CD44-targeted delivery of hydroxychloroquine to combat ' 'breast cancer metastasis in vitro and in vivo. Colloids Surf B ' 'Biointerfaces. 2022;210:112249. ' 'https://doi.org/10.1016/j.colsurfb.2021.112249.', 'journal-title': 'Colloids Surf B Biointerfaces.'}, { 'key': '2627_CR74', 'doi-asserted-by': 'publisher', 'first-page': '148', 'DOI': '10.1016/j.jconrel.2018.08.015', 'volume': '288', 'author': 'S Yin', 'year': '2018', 'unstructured': 'Yin S, Xia C, Wang Y, Wan D, Rao J, Tang X, et al. Dual receptor ' 'recognizing liposomes containing paclitaxel and hydroxychloroquine for ' 'primary and metastatic melanoma treatment via autophagy-dependent and ' 'independent pathways. J Control Release. 2018;288:148–60. ' 'https://doi.org/10.1016/j.jconrel.2018.08.015.', 'journal-title': 'J Control Release.'}, { 'key': '2627_CR75', 'first-page': '64', 'volume': '20', 'author': 'JW Moore', 'year': '1996', 'unstructured': 'Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. ' 'Pharm Technol. 1996;20:64–74.', 'journal-title': 'Pharm Technol.'}, { 'key': '2627_CR76', 'doi-asserted-by': 'publisher', 'unstructured': 'Tai T-T, Wu T-J, Wu H-D, Tsai Y-C, Wang H-T, Wang A-M, Shih S-F, Chen ' 'Y-C. A strategy to treat COVID-19 disease with targeted delivery of ' 'inhalable liposomal hydroxychloroquine: a pre-clinical pharmacokinetic ' 'study. Clin Transla Sci. 2020:14. https://doi.org/10.1111/cts.12923.', 'DOI': '10.1111/cts.12923'}, { 'key': '2627_CR77', 'doi-asserted-by': 'publisher', 'first-page': '897', 'DOI': '10.1023/A:1011928732588', 'volume': '15', 'author': 'J Emami', 'year': '1998', 'unstructured': 'Emami J, Pasutto FM, Jamali F. Effect of experimental diabetes mellitus ' 'and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers ' 'in rats. Pharm Res. 1998;15:897–903. ' 'https://doi.org/10.1023/A:1011928732588.', 'journal-title': 'Pharm Res.'}, { 'key': '2627_CR78', 'doi-asserted-by': 'publisher', 'first-page': '5', 'DOI': '10.1093/ilar.31.4.5', 'volume': '31', 'author': 'MW McGuill', 'year': '1989', 'unstructured': 'McGuill MW, Rowan AN. Biological effects of blood loss: implications for ' 'sampling volumes and techniques. ILAR J. 1989;31:5–20. ' 'https://doi.org/10.1093/ilar.31.4.5.', 'journal-title': 'ILAR J.'}, { 'key': '2627_CR79', 'doi-asserted-by': 'publisher', 'first-page': '320', 'DOI': '10.1016/j.jchromb.2017.11.026', 'volume': '1072', 'author': 'YS Chhonker', 'year': '2018', 'unstructured': 'Chhonker YS, Sleightholm RL, Li J, Oupický D, Murry DJ. Simultaneous ' 'quantitation of hydroxychloroquine and its metabolites in mouse blood ' 'and tissues using LC–ESI–MS/MS: an application for pharmacokinetic ' 'studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1072:320–7. ' 'https://doi.org/10.1016/j.jchromb.2017.11.026.', 'journal-title': 'J Chromatogr B Analyt Technol Biomed Life Sci.'}, { 'key': '2627_CR80', 'doi-asserted-by': 'publisher', 'first-page': '306', 'DOI': '10.1016/j.cmpb.2010.01.007', 'volume': '99', 'author': 'Y Zhang', 'year': '2010', 'unstructured': 'Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for ' 'pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. ' 'Comput Meth Prog Biomed. 2010;99:306–14. ' 'https://doi.org/10.1016/j.cmpb.2010.01.007.', 'journal-title': 'Comput Meth Prog Biomed.'}, { 'key': '2627_CR81', 'doi-asserted-by': 'publisher', 'first-page': '377', 'DOI': '10.1007/978-1-62703-050-2_16', 'volume-title': 'Computational toxicology methods in molecular biology', 'author': 'J Gabrielsson', 'year': '2012', 'unstructured': 'Gabrielsson J, Weiner D. Non-compartmental analysis. In: Reisfeld B, ' 'Mayeno A, editors. Computational toxicology methods in molecular ' 'biology. Totowa, NJ: Humana Press; 2012. p. 377–89.'}, { 'key': '2627_CR82', 'doi-asserted-by': 'publisher', 'unstructured': 'Amer MG, Mohamed NM. Potential use of quercetin as protective agent ' 'against hydroxychloroquine induced cardiotoxicity. J Biomed Res Environ ' 'Sci. 2021;2(185-92) https://doi.org/10.37871/jbres1208.', 'DOI': '10.37871/jbres1208'}, { 'key': '2627_CR83', 'doi-asserted-by': 'publisher', 'first-page': '1072', 'DOI': '10.1177/0192623316668276', 'volume': '44', 'author': 'K Kim', 'year': '2016', 'unstructured': 'Kim K, Chini N, Fairchild DG, Engle SK, Reagan WJ, Summers SD, et al. ' 'Evaluation of cardiac toxicity biomarkers in rats from different ' 'laboratories. Toxicol Pathol. 2016;44:1072–83. ' 'https://doi.org/10.1177/0192623316668276.', 'journal-title': 'Toxicol Pathol.'}, { 'key': '2627_CR84', 'unstructured': 'Roche. CKMB Creatine Kinase-MB. 2022. ' 'https://diagnostics.roche.com/global/en/products/product-category/molecular-diagnostics.html. ' 'Accessed 7 Nov 2022.'}, { 'key': '2627_CR85', 'unstructured': 'Roche. LDHI2 Lactate dehydrogenase acc. to IFCC ver.2. 2019. ' 'https://labogids.sintmaria.be/sites/default/files/files/ldhi2_2019-07_v12.pdf. ' 'Accessed 7 Nov 2022.'}, { 'key': '2627_CR86', 'doi-asserted-by': 'publisher', 'first-page': '190', 'DOI': '10.1177/1091581810392809', 'volume': '30', 'author': 'VD Roshan', 'year': '2011', 'unstructured': 'Roshan VD, Assali M, Moghaddam AH, Hosseinzadeh M, Myers J. Exercise ' 'training and antioxidants: effects on rat heart tissue exposed to lead ' 'acetate. Int J Toxicol. 2011;30:190–6. ' 'https://doi.org/10.1177/1091581810392809.', 'journal-title': 'Int J Toxicol.'}, { 'key': '2627_CR87', 'doi-asserted-by': 'publisher', 'first-page': '30', 'DOI': '10.46582/jsrm.0501006', 'volume': '5', 'author': 'G Srikanth', 'year': '2009', 'unstructured': 'Srikanth G, Prakash P, Tripathy N, Dikshit M, Nityanand S. Establishment ' 'of a rat model of myocardial infarction with a high survival rate: a ' 'suitable model for evaluation of efficacy of stem cell therapy. J Stem ' 'Cells Regen Med. 2009;5:30–6. https://doi.org/10.46582/jsrm.0501006.', 'journal-title': 'J Stem Cells Regen Med.'}, { 'key': '2627_CR88', 'doi-asserted-by': 'publisher', 'first-page': '326', 'DOI': '10.1016/j.ijcard.2006.03.016', 'volume': '115', 'author': 'K Karthikeyan', 'year': '2007', 'unstructured': 'Karthikeyan K, Bai BR, Devaraj SN. Cardioprotective effect of grape seed ' 'proanthocyanidins on isoproterenol-induced myocardial injury in rats. ' 'Int J Cardiol. 2007;115:326–33. ' 'https://doi.org/10.1016/j.ijcard.2006.03.016.', 'journal-title': 'Int J Cardiol.'}, { 'key': '2627_CR89', 'doi-asserted-by': 'publisher', 'first-page': '411', 'DOI': '10.1021/ci960402j', 'volume': '37', 'author': 'ML Swift', 'year': '1997', 'unstructured': 'Swift ML. GraphPad Prism, Data analysis, and scientific graphing. J Chem ' 'Inf Comput Sci. 1997;37:411–2. https://doi.org/10.1021/ci960402j.', 'journal-title': 'J Chem Inf Comput Sci.'}, { 'key': '2627_CR90', 'first-page': '21', 'volume': '2', 'author': 'NM Razali', 'year': '2011', 'unstructured': 'Razali NM, Wah YB. Power comparisons of shapiro-wilk, ' 'kolmogorov-smirnov, lilliefors and anderson-darling tests. JOSMA. ' '2011;2:21–33.', 'journal-title': 'JOSMA.'}, { 'key': '2627_CR91', 'doi-asserted-by': 'publisher', 'first-page': '199', 'DOI': '10.1007/978-981-16-8950-5', 'volume-title': 'Statistics in pharmacokinetics. Pharmacokinetics: basics to applications', 'author': 'B Mukherjee', 'year': '2022', 'unstructured': 'Mukherjee B. Statistics in pharmacokinetics. Pharmacokinetics: basics to ' 'applications. Singapore: Springer; 2022. p. 199–226.'}, { 'key': '2627_CR92', 'doi-asserted-by': 'publisher', 'unstructured': 'McKnight PE, Najab J. Mann-Whitney U Test. The Corsini encyclopedia of ' 'psychology. 2010: 1 https://doi.org/10.1002/9780470479216.corpsy0524.', 'DOI': '10.1002/9780470479216.corpsy0524'}, { 'key': '2627_CR93', 'doi-asserted-by': 'publisher', 'first-page': '5324', 'DOI': '10.1002/jps.22726', 'volume': '100', 'author': 'K Thelen', 'year': '2011', 'unstructured': 'Thelen K, Coboeken K, Willmann S, Burghaus R, Dressman JB, Lippert J. ' 'Evolution of a detailed physiological model to simulate the ' 'gastrointestinal transit and absorption process in humans, part 1: oral ' 'solutions. J Pharm Sci. 2011;100:5324–45. ' 'https://doi.org/10.1002/jps.22726.', 'journal-title': 'J Pharm Sci.'}, { 'key': '2627_CR94', 'doi-asserted-by': 'publisher', 'first-page': '132', 'DOI': '10.1111/cts.12923', 'volume': '14', 'author': 'T-T Tai', 'year': '2021', 'unstructured': 'Tai T-T, Wu T-J, Wu H-D, Tsai Y-C, Wang H-T, Wang A-M, et al. A strategy ' 'to treat COVID-19 disease with targeted delivery of inhalable liposomal ' 'hydroxychloroquine: a preclinical pharmacokinetic study. Clin Transl ' 'Sci. 2021;14:132–6. https://doi.org/10.1111/cts.12923.', 'journal-title': 'Clin Transl Sci.'}, { 'key': '2627_CR95', 'unstructured': 'Simulations Plus Inc. GastroPlus Manual. 2020. ' 'www.simulations-plus.com/wp-content/uploads/GastroPlus-9.8-Release-Notes.pdf. ' 'Accessed 20 Dec 2022.'}, { 'key': '2627_CR96', 'doi-asserted-by': 'publisher', 'first-page': '610', 'DOI': '10.1016/j.ejps.2016.10.036', 'volume': '96', 'author': 'A Margolskee', 'year': '2017', 'unstructured': 'Margolskee A, Darwich AS, Pepin X, Aarons L, Galetin A, Rostami-Hodjegan ' 'A, et al. IMI–oral biopharmaceutics tools project–evaluation of ' 'bottom-up PBPK prediction success part 2: an introduction to the ' 'simulation exercise and overview of results. Eur J Pharm Sci. ' '2017;96:610–25. https://doi.org/10.1016/j.ejps.2016.10.036.', 'journal-title': 'Eur J Pharm Sci.'}, { 'key': '2627_CR97', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.carpta.2021.100140', 'volume': '2', 'author': 'GC Zambuzi', 'year': '2021', 'unstructured': 'Zambuzi GC, Camargos CHM, Ferreira MP, Rezende CA, de Freitas O, ' 'Francisco KR. Modulating the controlled release of hydroxychloroquine ' 'mobilized on pectin films through film-forming pH and incorporation of ' 'nanocellulose. Carbohydrate polymers. 2021;2:100140. ' 'https://doi.org/10.1016/j.carpta.2021.100140.', 'journal-title': 'Carbohydrate polymers.'}, { 'key': '2627_CR98', 'doi-asserted-by': 'publisher', 'first-page': '2283', 'DOI': '10.1007/s10973-019-08953-8', 'volume': '140', 'author': 'ANF Moraes', 'year': '2020', 'unstructured': 'Moraes ANF, Silva LAD, de Oliveira MA, de Oliveira EM, Nascimento TL, ' 'Lima EM, et al. Compatibility study of hydroxychloroquine sulfate with ' 'pharmaceutical excipients using thermal and nonthermal techniques for ' 'the development of hard capsules. J Therm Anal Calorim. ' '2020;140:2283–92. https://doi.org/10.1007/s10973-019-08953-8.', 'journal-title': 'J Therm Anal Calorim.'}, { 'key': '2627_CR99', 'doi-asserted-by': 'publisher', 'first-page': '363', 'DOI': '10.1007/s11094-009-0304-1', 'volume': '43', 'author': 'F Barboza', 'year': '2009', 'unstructured': 'Barboza F, Vecchia DD, Tagliari MP, Silva MAS, Stulzer HK. Differential ' 'scanning calorimetry as a screening technique in compatibility studies ' 'of acyclovir extended release formulations. Pharm Chem J. 2009;43:363–8. ' 'https://doi.org/10.1007/s11094-009-0304-1.', 'journal-title': 'Pharm Chem J.'}, { 'key': '2627_CR100', 'first-page': '653', 'volume': '8', 'author': 'A Arianto', 'year': '2015', 'unstructured': 'Arianto A, Bangun H, Harahap U, Ilyas S. Effect of alginate chitosan ' 'ratio on the swelling, mucoadhesive, and release of ranitidine from ' 'spherical matrices of alginate-chitosan. Int J Pharmtech Res. ' '2015;8:653–65.', 'journal-title': 'Int J Pharmtech Res.'}, { 'key': '2627_CR101', 'doi-asserted-by': 'publisher', 'first-page': '255', 'DOI': '10.17350/HJSE19030000236', 'volume': '8', 'author': 'C Armutcu', 'year': '2021', 'unstructured': 'Armutcu C, Pişkin S. Evaluation of controlled hydroxychloroquine ' 'releasing performance from calcium-alginate beads. HJSE. 2021;8:255–63. ' 'https://doi.org/10.17350/HJSE19030000236.', 'journal-title': 'HJSE.'}, { 'key': '2627_CR102', 'doi-asserted-by': 'publisher', 'first-page': '24', 'DOI': '10.9790/5736-1111012434', 'volume': '11', 'author': 'MS Treasa', 'year': '2018', 'unstructured': 'Treasa MS, Premakumari J. Characterisation and solubility studies of ' 'quinine sulphate and hydroxychloroquine sulphate inclusion complexes ' 'with α–cyclodextrin. IOSR j appl chem. 2018;11:24–34. ' 'https://doi.org/10.9790/5736-1111012434.', 'journal-title': 'IOSR j appl chem.'}, { 'key': '2627_CR103', 'doi-asserted-by': 'publisher', 'unstructured': 'Einfalt T, Detampel P, Häussinger D, Casper J, Meier CR, Puchkov M, et ' 'al. Hydroxychloroquine immediate release tablets: formulation and ' 'evaluation of a solid dosage form. Biological and Medicinal. Chem. 2021; ' 'https://doi.org/10.26434/chemrxiv.14170508.v1.', 'DOI': '10.26434/chemrxiv.14170508.v1'}, { 'key': '2627_CR104', 'doi-asserted-by': 'publisher', 'first-page': '32', 'DOI': '10.1016/j.enmm.2016.06.008', 'volume': '6', 'author': 'R Dubey', 'year': '2016', 'unstructured': 'Dubey R, Bajpai J, Bajpai AK. Chitosan-alginate nanoparticles (CANPs) as ' 'potential nanosorbent for removal of Hg (II) ions. Environ Nanotechnol ' 'Monit Manag. 2016;6:32–44. https://doi.org/10.1016/j.enmm.2016.06.008.', 'journal-title': 'Environ Nanotechnol Monit Manag.'}, { 'key': '2627_CR105', 'doi-asserted-by': 'publisher', 'first-page': '555', 'DOI': '10.1023/A:1018879331061', 'volume': '16', 'author': 'A Ben-Jebria', 'year': '1999', 'unstructured': 'Ben-Jebria A, Chen D, Eskew ML, Vanbever R, Langer R, Edwards DA. Large ' 'porous particles for sustained protection from carbachol-induced ' 'bronchoconstriction in guinea pigs. Pharm Res. 1999;16:555–61. ' 'https://doi.org/10.1023/A:1018879331061.', 'journal-title': 'Pharm Res.'}, { 'key': '2627_CR106', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijpharm.2022.122042', 'volume': '624', 'author': 'T Saha', 'year': '2022', 'unstructured': 'Saha T, Quiñones-Mateu ME, Das SC. Inhaled therapy for COVID-19: ' 'considerations of drugs, formulations and devices. Int J Pharm. ' '2022;624:122042. https://doi.org/10.1016/j.ijpharm.2022.122042.', 'journal-title': 'Int J Pharm.'}, { 'key': '2627_CR107', 'doi-asserted-by': 'publisher', 'first-page': '268', 'DOI': '10.4062/biomolther.2021.032', 'volume': '29', 'author': 'JY Bae', 'year': '2021', 'unstructured': 'Bae JY, Lee GE, Park H, Cho J, Kim J, Lee J, et al. Antiviral efficacy ' 'of pralatrexate against SARS-CoV-2. Biomol Ther (Seoul). 2021;29:268–72. ' 'https://doi.org/10.4062/biomolther.2021.032.', 'journal-title': 'Biomol Ther (Seoul).'}, { 'key': '2627_CR108', 'doi-asserted-by': 'publisher', 'first-page': '198', 'DOI': '10.1016/j.ijpharm.2009.07.023', 'volume': '382', 'author': 'K Tahara', 'year': '2009', 'unstructured': 'Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. ' 'Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 ' 'cells. Int J Pharm. 2009;382:198–204. ' 'https://doi.org/10.1016/j.ijpharm.2009.07.023.', 'journal-title': 'Int J Pharm.'}, { 'key': '2627_CR109', 'doi-asserted-by': 'publisher', 'first-page': '460', 'DOI': '10.1208/s12249-010-9406-z', 'volume': '11', 'author': 'S Takka', 'year': '2010', 'unstructured': 'Takka S, Gürel A. Evaluation of chitosan/alginate beads using ' 'experimental design: formulation and in vitro characterization. AAPS ' 'PharmSciTech. 2010;11:460–6. https://doi.org/10.1208/s12249-010-9406-z.', 'journal-title': 'AAPS PharmSciTech.'}, { 'key': '2627_CR110', 'doi-asserted-by': 'publisher', 'first-page': '246', 'DOI': '10.1166/jbt.2015.1299', 'volume': '5', 'author': 'M Jia', 'year': '2015', 'unstructured': 'Jia M, Li Z-B, Chu H-T, Li L, Chen K-Y. Alginate-chitosan microspheres ' 'for controlled drug delivery of diltiazem hydrochloride in cardiac ' 'diseases. J Biomater Tissue Eng. 2015;5:246–51. ' 'https://doi.org/10.1166/jbt.2015.1299.', 'journal-title': 'J Biomater Tissue Eng.'}, { 'key': '2627_CR111', 'doi-asserted-by': 'publisher', 'first-page': '9281', 'DOI': '10.1016/j.actbio.2013.08.002', 'volume': '9', 'author': 'G Chan', 'year': '2013', 'unstructured': 'Chan G, Mooney DJ. Ca2+ released from calcium alginate gels can promote ' 'inflammatory responses in vitro and in vivo. Acta Biomater. ' '2013;9:9281–91. https://doi.org/10.1016/j.actbio.2013.08.002.', 'journal-title': 'Acta Biomater.'}, { 'key': '2627_CR112', 'unstructured': 'USFDA. Physiologically based pharmacokinetic analyses-format and content ' 'guidance for industry. 2019. ' 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/physiologically-based-pharmacokinetic-analyses-format-and-content-guidance-industry. ' 'Accessed 26 Oct 2022.'}, { 'key': '2627_CR113', 'doi-asserted-by': 'publisher', 'first-page': '390', 'DOI': '10.1124/dmd.116.074450', 'volume': '45', 'author': 'C Ono', 'year': '2017', 'unstructured': 'Ono C, Hsyu P-H, Abbas R, Loi C-M, Yamazaki S. Application of ' 'physiologically based pharmacokinetic modeling to the understanding of ' 'bosutinib pharmacokinetics: prediction of drug–drug and drug–disease ' 'interactions. Drug Metab Dispos. 2017;45:390–8. ' 'https://doi.org/10.1124/dmd.116.074450.', 'journal-title': 'Drug Metab Dispos.'}, { 'key': '2627_CR114', 'doi-asserted-by': 'publisher', 'first-page': '481', 'DOI': '10.1208/s12249-016-0492-4', 'volume': '18', 'author': 'RM Obaidat', 'year': '2017', 'unstructured': 'Obaidat RM, Tashtoush BM, Awad AA, Al Bustami RT. Using supercritical ' 'fluid technology (SFT) in preparation of tacrolimus solid dispersions. ' 'AAPS PharmSciTech. 2017;18:481–93. ' 'https://doi.org/10.1208/s12249-016-0492-4.', 'journal-title': 'AAPS PharmSciTech.'}, { 'key': '2627_CR115', 'doi-asserted-by': 'publisher', 'first-page': '1378', 'DOI': '10.1016/j.carbpol.2012.02.023', 'volume': '88', 'author': 'C García-González', 'year': '2012', 'unstructured': 'García-González C, Uy J, Alnaief M, Smirnova I. Preparation of ' 'tailor-made starch-based aerogel microspheres by the emulsion-gelation ' 'method. Carbohydr Polym. 2012;88:1378–86. ' 'https://doi.org/10.1016/j.carbpol.2012.02.023.', 'journal-title': 'Carbohydr Polym.'}, { 'key': '2627_CR116', 'doi-asserted-by': 'publisher', 'first-page': '84', 'DOI': '10.1016/j.supflu.2014.04.014', 'volume': '91', 'author': 'MA Marin', 'year': '2014', 'unstructured': 'Marin MA, Mallepally RR, McHugh MA. Silk fibroin aerogels for drug ' 'delivery applications. J Supercrit Fluids. 2014;91:84–9. ' 'https://doi.org/10.1016/j.supflu.2014.04.014.', 'journal-title': 'J Supercrit Fluids.'}, { 'key': '2627_CR117', 'doi-asserted-by': 'publisher', 'first-page': '310', 'DOI': '10.1016/j.supflu.2016.05.033', 'volume': '120', 'author': 'Z Ulker', 'year': '2017', 'unstructured': 'Ulker Z, Erkey C. An advantageous technique to load drugs into aerogels: ' 'gas antisolvent crystallization inside the pores. J Supercrit Fluids. ' '2017;120:310–9. https://doi.org/10.1016/j.supflu.2016.05.033.', 'journal-title': 'J Supercrit Fluids.'}, { 'key': '2627_CR118', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.2217/17435889.3.1.1', 'volume': '3', 'author': 'M Smola', 'year': '2008', 'unstructured': 'Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug ' 'delivery systems to treat and to diagnose respiratory and non ' 'respiratory diseases. Int J Nanomedicine. 2008;3:1–19.', 'journal-title': 'Int J Nanomedicine.'}, { 'key': '2627_CR119', 'doi-asserted-by': 'publisher', 'first-page': '2643', 'DOI': '10.1016/j.actbio.2014.01.033', 'volume': '10', 'author': 'JU Menon', 'year': '2014', 'unstructured': 'Menon JU, Ravikumar P, Pise A, Gyawali D, Hsia CC, Nguyen KT. Polymeric ' 'nanoparticles for pulmonary protein and DNA delivery. Acta Biomater. ' '2014;10:2643–52. https://doi.org/10.1016/j.actbio.2014.01.033.', 'journal-title': 'Acta Biomater.'}, { 'key': '2627_CR120', 'doi-asserted-by': 'publisher', 'first-page': '624', 'DOI': '10.1007/s11814-020-0719-7', 'volume': '38', 'author': 'JM George', 'year': '2021', 'unstructured': 'George JM, Mathew B. Cyclodextrin-mediated gold nanoparticles as ' 'multisensing probe for the selective detection of hydroxychloroquine ' 'drug. Korean J Chem Eng. 2021;38:624–34. ' 'https://doi.org/10.1007/s11814-020-0719-7.', 'journal-title': 'Korean J Chem Eng.'}, { 'key': '2627_CR121', 'doi-asserted-by': 'publisher', 'first-page': '2209', 'DOI': '10.31788/RJC.2021.1446508', 'volume': '14', 'author': 'SG Reddy', 'year': '2021', 'unstructured': 'Reddy SG. Controlled release studies of hydroxychloroquine sulphate ' '(Hcq) drug-using biodegradable polymeric sodium alginate and ' 'lignosulphonic acid blends. Rasayan J Chem. 2021;14:2209–15.', 'journal-title': 'Rasayan J Chem.'}, { 'key': '2627_CR122', 'doi-asserted-by': 'publisher', 'first-page': '466', 'DOI': '10.1016/j.ijbiomac.2014.08.020', 'volume': '72', 'author': 'AF Martins', 'year': '2015', 'unstructured': 'Martins AF, Facchi SP, Monteiro JP, Nocchi SR, Silva CTP, Nakamura CV, ' 'et al. Preparation and cytotoxicity of N, N, N-trimethyl ' 'chitosan/alginate beads containing gold nanoparticles. Int J Biol ' 'Macromol. 2015;72:466–71. ' 'https://doi.org/10.1016/j.ijbiomac.2014.08.020.', 'journal-title': 'Int J Biol Macromol.'}, { 'key': '2627_CR123', 'first-page': '119', 'volume': '19', 'author': 'MH Shoaib', 'year': '2006', 'unstructured': 'Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release ' 'kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci. ' '2006;19:119–24.', 'journal-title': 'Pak J Pharm Sci.'}, { 'key': '2627_CR124', 'first-page': '77', 'volume': '2', 'author': 'G Singhvi', 'year': '2011', 'unstructured': 'Singhvi G, Singh M. In-vitro drug release characterization models. Int J ' 'Pharm Stud Res. 2011;2:77–84.', 'journal-title': 'Int J Pharm Stud Res.'}, { 'key': '2627_CR125', 'doi-asserted-by': 'publisher', 'first-page': '151', 'DOI': '10.2147/IJN.S15057', 'volume': '6', 'author': 'S Nie', 'year': '2011', 'unstructured': 'Nie S, Hsiao WLW, Pan W, Yang Z. Thermoreversible Pluronic® F127-based ' 'hydrogel containing liposomes for the controlled delivery of paclitaxel: ' 'in vitro drug release, cell cytotoxicity, and uptake studies. Int J ' 'Nanomedicine. 2011;6:151–66. https://doi.org/10.2147/IJN.S15057.', 'journal-title': 'Int J Nanomedicine.'}, { 'key': '2627_CR126', 'doi-asserted-by': 'publisher', 'first-page': '25', 'DOI': '10.1016/0378-5173(83)90064-9', 'volume': '15', 'author': 'RW Korsmeyer', 'year': '1983', 'unstructured': 'Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of ' 'solute release from porous hydrophilic polymers. Int J Pharm. ' '1983;15:25–35. https://doi.org/10.1016/0378-5173(83)90064-9.', 'journal-title': 'Int J Pharm.'}, { 'key': '2627_CR127', 'doi-asserted-by': 'publisher', 'first-page': '276', 'DOI': '10.1016/j.ejpb.2011.04.017', 'volume': '79', 'author': 'KK Gill', 'year': '2011', 'unstructured': 'Gill KK, Nazzal S, Kaddoumi A. Paclitaxel loaded PEG5000–DSPE micelles ' 'as pulmonary delivery platform: formulation characterization, tissue ' 'distribution, plasma pharmacokinetics, and toxicological evaluation. Eur ' 'J Pharm Biopharm. 2011;79:276–84. ' 'https://doi.org/10.1016/j.ejpb.2011.04.017.', 'journal-title': 'Eur J Pharm Biopharm.'}, { 'key': '2627_CR128', 'doi-asserted-by': 'publisher', 'first-page': '589', 'DOI': '10.1080/08958370390205083', 'volume': '15', 'author': 'ID Dobrev', 'year': '2003', 'unstructured': 'Dobrev ID, Reddy MB, Plotzke KP, Varaprath S, McNett DA, Durham J, et ' 'al. Closed-chamber inhalation pharmacokinetic studies with ' 'hexamethyldisiloxane in the rat. Inhal Toxicol. 2003;15:589–617. ' 'https://doi.org/10.1080/08958370390205083.', 'journal-title': 'Inhal Toxicol.'}, { 'key': '2627_CR129', 'doi-asserted-by': 'publisher', 'first-page': '217', 'DOI': '10.1089/jamp.2011.0933', 'volume': '25', 'author': 'J Mitchell', 'year': '2012', 'unstructured': 'Mitchell J, Dolovich MB. Clinically relevant test methods to establish ' 'in vitro equivalence for spacers and valved holding chambers used with ' 'pressurized metered dose inhalers (pMDIs). J Aerosol Med Pulm Drug ' 'Deliv. 2012;25:217–42. https://doi.org/10.1089/jamp.2011.0933.', 'journal-title': 'J Aerosol Med Pulm Drug Deliv.'}, { 'key': '2627_CR130', 'doi-asserted-by': 'publisher', 'first-page': '160', 'DOI': '10.1016/j.ejpb.2016.07.003', 'volume': '107', 'author': 'VSS Gonçalves', 'year': '2016', 'unstructured': 'Gonçalves VSS, Gurikov P, Poejo J, Matias AA, Heinrich S, Duarte CMM, et ' 'al. Alginate-based hybrid aerogel microparticles for mucosal drug ' 'delivery. Eur J Pharm Biopharm. 2016;107:160–70. ' 'https://doi.org/10.1016/j.ejpb.2016.07.003.', 'journal-title': 'Eur J Pharm Biopharm.'}, { 'key': '2627_CR131', 'doi-asserted-by': 'publisher', 'first-page': '796', 'DOI': '10.3390/gels8120796', 'volume': '8', 'author': 'N Menshutina', 'year': '2022', 'unstructured': 'Menshutina N, Majouga A, Uvarova A, Lovskaya D, Tsygankov P, Mochalova ' 'M, et al. Chitosan aerogel particles as nasal drug delivery systems. ' 'Gels. 2022;8:796. https://doi.org/10.3390/gels8120796.', 'journal-title': 'Gels.'}, { 'key': '2627_CR132', 'doi-asserted-by': 'publisher', 'first-page': '964', 'DOI': '10.1016/j.biopha.2019.01.014', 'volume': '111', 'author': 'FP Soorbaghi', 'year': '2019', 'unstructured': 'Soorbaghi FP, Isanejad M, Salatin S, Ghorbani M, Jafari S, ' 'Derakhshankhah H. Bioaerogels: synthesis approaches, cellular uptake, ' 'and the biomedical applications. Biomed Pharmacother. 2019;111:964–75. ' 'https://doi.org/10.1016/j.biopha.2019.01.014.', 'journal-title': 'Biomed Pharmacother.'}, { 'key': '2627_CR133', 'doi-asserted-by': 'publisher', 'first-page': '83', 'DOI': '10.1016/j.ejpb.2013.06.024', 'volume': '86', 'author': 'HX Ong', 'year': '2014', 'unstructured': 'Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, et al. In ' 'vitro and ex vivo methods predict the enhanced lung residence time of ' 'liposomal ciprofloxacin formulations for nebulisation. Eur J Pharm ' 'Biopharm. 2014;86:83–9. https://doi.org/10.1016/j.ejpb.2013.06.024.', 'journal-title': 'Eur J Pharm Biopharm.'}, { 'key': '2627_CR134', 'doi-asserted-by': 'publisher', 'first-page': '387', 'DOI': '10.3390/pharmaceutics12040387', 'volume': '12', 'author': 'J Brillault', 'year': '2020', 'unstructured': 'Brillault J, Tewes F. Control of the lung residence time of highly ' 'permeable molecules after nebulization: example of the fluoroquinolones. ' 'Pharmaceutics. 2020;12:387. ' 'https://doi.org/10.3390/pharmaceutics12040387.', 'journal-title': 'Pharmaceutics.'}, { 'key': '2627_CR135', 'doi-asserted-by': 'publisher', 'unstructured': 'Borghardt JM, Kloft C, Sharma A. Inhaled therapy in respiratory disease: ' 'the complex interplay of pulmonary kinetic processes. Can Respir J. ' '2018; 2018. https://doi.org/10.1155/2018/2732017.', 'DOI': '10.1155/2018/2732017'}, { 'key': '2627_CR136', 'doi-asserted-by': 'publisher', 'first-page': '3519', 'DOI': '10.3390/ijms15033519', 'volume': '15', 'author': 'H Wang', 'year': '2014', 'unstructured': 'Wang H, Xu Y, Zhou X. Docetaxel-loaded chitosan microspheres as a lung ' 'targeted drug delivery system: in vitro and in vivo evaluation. Int J ' 'Mol Sci. 2014;15:3519–32. https://doi.org/10.3390/ijms15033519.', 'journal-title': 'Int J Mol Sci.'}, { 'key': '2627_CR137', 'doi-asserted-by': 'publisher', 'first-page': '304', 'DOI': '10.1016/j.advms.2021.07.001', 'volume': '66', 'author': 'A Zinellu', 'year': '2021', 'unstructured': 'Zinellu A, Sotgia S, Fois AG, Mangoni AA. Serum CK-MB, COVID-19 severity ' 'and mortality: an updated systematic review and meta-analysis with ' 'meta-regression. Adv Med Sci. 2021;66:304–14. ' 'https://doi.org/10.1016/j.advms.2021.07.001.', 'journal-title': 'Adv Med Sci.'}, { 'key': '2627_CR138', 'doi-asserted-by': 'publisher', 'first-page': '115', 'DOI': '10.1006/phrs.1999.0630', 'volume': '42', 'author': 'HE Mohamed', 'year': '2000', 'unstructured': 'Mohamed HE, El-Swefy SE, Hagar HH. The protective effect of glutathione ' 'administration on adriamycin-induced acute cardiac toxicity in rats. ' 'Pharmacol Res. 2000;42:115–21. https://doi.org/10.1006/phrs.1999.0630.', 'journal-title': 'Pharmacol Res.'}, { 'key': '2627_CR139', 'doi-asserted-by': 'publisher', 'first-page': '1947', 'DOI': '10.1128/AAC.35.10.1947', 'volume': '35', 'author': 'DE Nix', 'year': '1991', 'unstructured': 'Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag J. Antibiotic ' 'tissue penetration and its relevance: models of tissue penetration and ' 'their meaning. Antimicrob Agents Chemother. 1991;35:1947–52. ' 'https://doi.org/10.1128/AAC.35.10.1947.', 'journal-title': 'Antimicrob Agents Chemother.'}, { 'key': '2627_CR140', 'doi-asserted-by': 'publisher', 'first-page': '1304', 'DOI': '10.1164/rccm.200301-111OC', 'volume': '168', 'author': 'K Yamazaki', 'year': '2003', 'unstructured': 'Yamazaki K, Ogura S, Ishizaka A, Oh-hara T, Nishimura M. Bronchoscopic ' 'microsampling method for measuring drug concentration in epithelial ' 'lining fluid. Am J Respir Crit Care Med. 2003;168:1304–7. ' 'https://doi.org/10.1164/rccm.200301-111OC.', 'journal-title': 'Am J Respir Crit Care Med.'}, { 'key': '2627_CR141', 'doi-asserted-by': 'publisher', 'first-page': '87', 'DOI': '10.1515/dmpt-2022-0130', 'volume': '38', 'author': 'MM Alsmadi', 'year': '2022', 'unstructured': 'Alsmadi MM. The investigation of the complex population-drug-drug ' 'interaction between ritonavir-boosted lopinavir and chloroquine or ' 'ivermectin using physiologically-based pharmacokinetic modeling. Drug ' 'Metab Pers Ther. 2022;38:87–105. https://doi.org/10.1515/dmpt-2022-0130.', 'journal-title': 'Drug Metab Pers Ther.'}, { 'key': '2627_CR142', 'doi-asserted-by': 'publisher', 'first-page': '1266', 'DOI': '10.3201/eid2606.200516', 'volume': '26', 'author': 'J Harcourt', 'year': '2020', 'unstructured': 'Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, et al. ' 'Severe acute respiratory syndrome coronavirus 2 from patient with ' 'coronavirus disease. United States. Emerg Infect Dis. 2020;26:1266–73. ' 'https://doi.org/10.3201/eid2606.200516.', 'journal-title': 'United States. Emerg Infect Dis.'}, { 'key': '2627_CR143', 'doi-asserted-by': 'publisher', 'first-page': '77', 'DOI': '10.1126/science.abc1932', 'volume': '369', 'author': 'Q Gao', 'year': '2020', 'unstructured': 'Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an ' 'inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369:77–81. ' 'https://doi.org/10.1126/science.abc1932.', 'journal-title': 'Science.'}, { 'key': '2627_CR144', 'doi-asserted-by': 'publisher', 'unstructured': 'Shuai H, Chan JF-W, Hu B, Chai Y, Yuen TT-T, Yin F, et al. Attenuated ' 'replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron. Nature. ' '2022:1. https://doi.org/10.1038/s41586-022-04442-5.', 'DOI': '10.1038/s41586-022-04442-5'}, { 'key': '2627_CR145', 'doi-asserted-by': 'publisher', 'first-page': '105253', 'DOI': '10.1016/j.antiviral.2022.105253', 'volume': '198', 'author': 'R Abdelnabi', 'year': '2022', 'unstructured': 'Abdelnabi R, Foo CS, Zhang X, Lemmens V, Maes P, Slechten B, et al. The ' 'omicron (B. 1.1. 529) SARS-CoV-2 variant of concern does not readily ' 'infect Syrian hamsters. Antiviral Res. 2022;198:105253. ' 'https://doi.org/10.1016/j.antiviral.2022.105253.', 'journal-title': 'Antiviral Res.'}, { 'key': '2627_CR146', 'doi-asserted-by': 'publisher', 'first-page': '3771', 'DOI': '10.1021/acs.jcim.1c00384', 'volume': '61', 'author': 'H Mslati', 'year': '2021', 'unstructured': 'Mslati H, Gentile F, Perez C, Cherkasov A. Comprehensive consensus ' 'analysis of SARS-CoV-2 drug repurposing campaigns. J Chem Inf Model. ' '2021;61:3771–88. https://doi.org/10.1021/acs.jcim.1c00384.', 'journal-title': 'J Chem Inf Model.'}, { 'key': '2627_CR147', 'doi-asserted-by': 'publisher', 'first-page': '598', 'DOI': '10.1002/chir.530070807', 'volume': '7', 'author': 'Y Wei', 'year': '1995', 'unstructured': 'Wei Y, Nygard GA, Ellertson SL, Khalil SK. Stereoselective disposition ' 'of hydroxychloroquine and its metabolites in rats. Chirality. ' '1995;7:598–604. https://doi.org/10.1002/chir.530070807.', 'journal-title': 'Chirality.'}, { 'key': '2627_CR148', 'doi-asserted-by': 'publisher', 'first-page': '1259', 'DOI': '10.1002/jps.20322', 'volume': '94', 'author': 'T Rodgers', 'year': '2005', 'unstructured': 'Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic ' 'modeling 1: predicting the tissue distribution of moderate-to-strong ' 'bases. J Pharm Sci. 2005;94:1259–76. https://doi.org/10.1002/jps.20322.', 'journal-title': 'J Pharm Sci.'}, { 'key': '2627_CR149', 'doi-asserted-by': 'publisher', 'first-page': '1260', 'DOI': '10.3390/pharmaceutics13081260', 'volume': '13', 'author': 'W Tai', 'year': '2021', 'unstructured': 'Tai W, Chow MYT, Chang RYK, Tang P, Gonda I, MacArthur RB, et al. ' 'Nebulised isotonic hydroxychloroquine aerosols for potential treatment ' 'of COVID-19. Pharmaceutics. 2021;13:1260. ' 'https://doi.org/10.3390/pharmaceutics13081260.', 'journal-title': 'Pharmaceutics.'}, { 'key': '2627_CR150', 'doi-asserted-by': 'publisher', 'first-page': '281', 'DOI': '10.1007/s40262-021-01066-2', 'volume': '61', 'author': 'NA Miller', 'year': '2022', 'unstructured': 'Miller NA, Graves RH, Edwards CD, Amour A, Taylor E, Robb O, et al. ' 'Physiologically based pharmacokinetic modelling of inhaled nemiralisib: ' 'mechanistic components for pulmonary absorption, systemic distribution, ' 'and oral absorption. Clin Pharmacokinet. 2022;61:281–93. ' 'https://doi.org/10.1007/s40262-021-01066-2.', 'journal-title': 'Clin Pharmacokinet.'}, { 'key': '2627_CR151', 'doi-asserted-by': 'publisher', 'first-page': '263', 'DOI': '10.1208/s12248-010-9185-1', 'volume': '12', 'author': 'Y Zhang', 'year': '2010', 'unstructured': 'Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in ' 'program for modeling and comparison of drug dissolution profiles. AAPS ' 'J. 2010;12:263–71. https://doi.org/10.1208/s12248-010-9185-1.', 'journal-title': 'AAPS J.'}], 'container-title': 'AAPS PharmSciTech', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1208/s12249-023-02627-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1208/s12249-023-02627-3/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1208/s12249-023-02627-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 8, 11]], 'date-time': '2023-08-11T14:02:43Z', 'timestamp': 1691762563000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1208/s12249-023-02627-3'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 8, 11]]}, 'references-count': 151, 'journal-issue': {'issue': '6', 'published-online': {'date-parts': [[2023, 8]]}}, 'alternative-id': ['2627'], 'URL': 'http://dx.doi.org/10.1208/s12249-023-02627-3', 'relation': {}, 'ISSN': ['1530-9932'], 'subject': [ 'Drug Discovery', 'Pharmaceutical Science', 'Agronomy and Crop Science', 'Ecology', 'Aquatic Science', 'General Medicine', 'Ecology, Evolution, Behavior and Systematics'], 'container-title-short': 'AAPS PharmSciTech', 'published': {'date-parts': [[2023, 8, 11]]}, 'assertion': [ { 'value': '20 April 2023', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '21 July 2023', 'order': 2, 'name': 'revised', 'label': 'Revised', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '25 July 2023', 'order': 3, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '11 August 2023', 'order': 4, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors declare no competing interests.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of Interest'}}], 'article-number': '172'}